SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)
BCRX 7.080+0.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: SemiBull who started this subject1/14/2004 5:10:23 PM
From: SemiBull  Read Replies (1) of 269
 
Biocryst files to offer $60 mln in common stock

Tuesday December 16, 4:48 pm ET

WASHINGTON, Dec 16 (Reuters) - Biocryst Pharmaceuticals Inc. (NasdaqNM:BCRX - News) filed with the U.S. Securities and Exchange Commission (News - Websites) on Tuesday to periodically sell up to $60 million in common stock.

Net proceeds from the offering will be used for general corporate purposes, the Birmingham, Alabama-based biotechnology firm said in a shelf registration statement.

Biocryst shares closed 22 cents lower Tuesday at $6.44 on the Nasdaq stock market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext